Skip to main content

The Synergistic Effects of Astragalus mongholicus and Salvia miltiorrhiza on Coronary Heart Disease Identified by Network Pharmacology and Experiment.

Publication ,  Journal Article
Zhang, Y; Wang, J; Liu, Y-M; Chen, Y-Y; Yang, X-C; Duan, L
Published in: Drug Des Devel Ther
2021

BACKGROUND AND PURPOSE: Two Chinese herbal medicines Huang Qi (HQ, Astragalus mongholicus) and Dan Shen (DS, Salvia miltiorrhiza) are often combined to treat coronary heart disease (CHD). The purpose of this study was to identify the underlying synergistic effects and mechanisms of HQ and DS against CHD. METHODS: The active components and targets of HQ and DS, CHD-related genes, and the biological progression were analysed by network pharmacology. The myocardial infarction (MI) rat model was established by ligating the left anterior descending coronary artery. Cardiac function was detected by ultrasonic electrocardiography. The MI size, fibrosis, cardiac hypertrophy, lipid metabolism, blood viscosity, and coagulation indexes were analysed by histological staining or chemical methods, respectively. RESULTS: A total of 170 shared and specific seed genes of HQ and DS against CHD were identified. The shared and specific biological processes of HQ and DS against CHD were obtained. The LVEF and LVFS values significantly increased, the myocardium infarct size and fibrosis significantly decreased, the values of lipid metabolism indexes and blood viscosity indexes significantly reduced in the HQ + DS treatment group vs HQ or DS single treatment (P < 0.05); the LVEDd, LVEDs, and the CSA values significantly reduced in HQ single and HQ + DS treatment groups vs MI group (P < 0.05); the coagulation index (APTT, PT, TT, and FIB) values decreased significantly in the DS single and HQ + DS treatment groups vs MI group (P < 0.05). CONCLUSION: In MI rats, HQ and DS exhibited synergistic effects on improving cardiac function, reducing MI size, fibrosis, regulating hyperlipidaemia, and maintaining circulatory system homeostasis; HQ had the specific advantage of alleviating cardiac remodelling; DS had the specific advantage of regulating hypercoagulability. This study revealed that HQ and DS not only exerted synergistic effects but also exhibited complementary effects on CHD.

Duke Scholars

Published In

Drug Des Devel Ther

DOI

EISSN

1177-8881

Publication Date

2021

Volume

15

Start / End Page

4053 / 4069

Location

New Zealand

Related Subject Headings

  • Ventricular Function, Left
  • Stroke Volume
  • Salvia miltiorrhiza
  • Rats, Sprague-Dawley
  • Rats
  • Network Pharmacology
  • Myocardial Infarction
  • Male
  • Drugs, Chinese Herbal
  • Drug Synergism
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Zhang, Y., Wang, J., Liu, Y.-M., Chen, Y.-Y., Yang, X.-C., & Duan, L. (2021). The Synergistic Effects of Astragalus mongholicus and Salvia miltiorrhiza on Coronary Heart Disease Identified by Network Pharmacology and Experiment. Drug Des Devel Ther, 15, 4053–4069. https://doi.org/10.2147/DDDT.S326024
Zhang, Yun, Jie Wang, Yong-Mei Liu, Yin-Ying Chen, Xiao-Chen Yang, and Lian Duan. “The Synergistic Effects of Astragalus mongholicus and Salvia miltiorrhiza on Coronary Heart Disease Identified by Network Pharmacology and Experiment.Drug Des Devel Ther 15 (2021): 4053–69. https://doi.org/10.2147/DDDT.S326024.
Zhang, Yun, et al. “The Synergistic Effects of Astragalus mongholicus and Salvia miltiorrhiza on Coronary Heart Disease Identified by Network Pharmacology and Experiment.Drug Des Devel Ther, vol. 15, 2021, pp. 4053–69. Pubmed, doi:10.2147/DDDT.S326024.

Published In

Drug Des Devel Ther

DOI

EISSN

1177-8881

Publication Date

2021

Volume

15

Start / End Page

4053 / 4069

Location

New Zealand

Related Subject Headings

  • Ventricular Function, Left
  • Stroke Volume
  • Salvia miltiorrhiza
  • Rats, Sprague-Dawley
  • Rats
  • Network Pharmacology
  • Myocardial Infarction
  • Male
  • Drugs, Chinese Herbal
  • Drug Synergism